EUVIMEDEUVIMED entdecken
Übersichtsarbeit

How the Versatile Self‐Assembly in Drug Delivery System to Afford Multimodal Cancer Therapy?

Yuqi Cao, Xiaomin Zhao, Yuhang Miao, Xin Wang, Dawei Deng iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202403715 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yuqi Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering and Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 2…. Hauptthemen laut MEDLINE: Neoplasms, Drug Delivery Systems, Antineoplastic Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 233 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Double First-Rate Construction Plan of China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid development of self‐assembly technology during the past few decades has effectively addressed plenty of the issues associated with carrier‐based drug delivery systems, such as low loading efficiency, complex fabrication processes, and inherent toxicity of carriers. The integration of nanoscale delivery systems with self‐assembly techniques has enabled efficient and targeted self‐administration of drugs, enhanced bioavailability, prolonged circulation time, and controllable drug release. Concurrently, the limitations of single‐mode cancer treatment, including low bioavailability, poor therapeutic outcomes, and significant side effects, have highlighted the urgent need for multimodal combined antitumor therapies. Set against the backdrop of multimodal cancer therapy, this review summarizes the research progress and applications of a large number of self‐assembled drug delivery platforms, including natural small molecule self‐assembled, carrier‐free self‐assembled, amphiphilic polymer‐based self‐assembled, peptide‐based self‐assembled, and metal‐based self‐assembled nano drug delivery systems. This review particularly analyzes the latest advances in the application of self‐assembled nano drug delivery platforms in combined antitumor therapies mediated by chemotherapy, phototherapy, radiotherapy, sonodynamic therapy, and immunotherapy, providing innovative research insights for further optimization and expansion of self‐assembled nano drug delivery systems in the clinical translation and development of antitumor combined therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDrug Delivery SystemsAntineoplastic AgentsHumansAnimalsCombined Modality TherapyNanoparticlesDrug Carriers

Stichwörter der Autor:innen

clinical translation and developmentmultifunctional nanomaterialmultimodal cancer therapynano drug delivery systemself‐assembly

Substanzen

Antineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Department of Pharmaceutical Engineering and Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198, China.

ORCID-Profile: Dawei Deng

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Double First-Rate Construction Plan of China Pharmaceutical University
  • Jiangsu Provincial Natural Science Fund for Distinguished Young Scholars
  • National Key Research and Development Program of China

Zitieren

APA

Cao, Y., Zhao, X., Miao, Y., Wang, X., & Deng, D. (2025). How the Versatile Self‐Assembly in Drug Delivery System to Afford Multimodal Cancer Therapy?. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403715

Vancouver

Cao Y, Zhao X, Miao Y, Wang X, Deng D. How the Versatile Self‐Assembly in Drug Delivery System to Afford Multimodal Cancer Therapy?. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403715

BibTeX
@article{Cao2025,
  author = {Cao, Yuqi and Zhao, Xiaomin and Miao, Yuhang and Wang, Xin and Deng, Dawei},
  title = {How the Versatile Self‐Assembly in Drug Delivery System to Afford Multimodal Cancer Therapy?},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202403715}
}
Kostenlos starten →